Literature DB >> 15616118

Autologous chondrocyte implantation in knee joint: MR imaging and histologic features at 1-year follow-up.

Bernhard J Tins1, Iain W McCall, Tomoki Takahashi, Victor Cassar-Pullicino, Sally Roberts, Brian Ashton, James Richardson.   

Abstract

PURPOSE: To evaluate magnetic resonance (MR) imaging features of autologous chondrocyte implantation (ACI) grafts and compare these with graft histologic features 1 year after ACI for treatment of femoral condylar defects.
MATERIALS AND METHODS: This study was approved by the regional ethics committee, and all patients gave informed consent. Forty-one patients (mean age, 35 years; 30 men, 11 women) underwent ACI for treatment of femoral condylar defects. One year later, knee joint MR imaging and graft biopsy were performed. Graft biopsy results were categorized into those showing hyaline, mixed fibrohyaline cartilage, fibrocartilage, and fibrous tissue. Standard T1-, T2-, T2*-, and intermediate-weighted sequences were performed, as well as three-dimensional (3D) fast low-angle shot (FLASH) and double-echo steady-state sequences for cartilage assessment. ACI grafts were assessed for signal intensity (with FLASH sequence), thickness, overgrowth, surface smoothness, integration to adjacent cartilage and underlying bone, bone marrow edema underneath graft, and contour of bone underneath graft. MR images were assessed by two observers, first independently and then in consensus. MR imaging findings were correlated with histologic findings.
RESULTS: All 41 grafts were present at 1-year follow-up. The graft consisted of hyaline cartilage in four, mixed fibrohyaline cartilage in 10, fibrocartilage in 25, and fibrous tissue in two cases. Graft signal intensity was virtually always lower than adjacent normal cartilage signal intensity, and there was no relationship between graft signal intensity and histologic appearance (P = .34). Graft thickness (P = .83), overgrowth (P = .69), surface smoothness (P = .28), and integration with adjacent cartilage and underlying bone (P = .90); edema in bone marrow underneath graft (P = .63); and bone contour underneath graft (P = .94) at MR imaging had no correlation with graft histologic appearance. Graft overgrowth (n = 16; 39%) and edema-like signal in bone marrow underneath graft (n = 23; 56%) were common. The origin of graft overgrowth remains unclear.
CONCLUSION: With the methods presented here, MR imaging findings cannot predict ACI graft histologic features, and graft histologic appearance determined at biopsy was not related to graft signal intensity, graft thickness, overgrowth, surface smoothness, integration with adjacent cartilage or underlying bone, signal intensity change in underlying bone marrow, or underlying bone contour. Overgrowth and bone marrow changes underneath the graft were common. (c) RSNA, 2004.

Entities:  

Mesh:

Year:  2004        PMID: 15616118     DOI: 10.1148/radiol.2342031970

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  39 in total

1.  Matrix-induced autologous chondrocyte implantation (MACI) in the knee.

Authors:  Davide Enea; Stefano Cecconi; Alberto Busilacchi; Sandra Manzotti; Rosaria Gesuita; Antonio Gigante
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-08-12       Impact factor: 4.342

Review 2.  MR imaging of autologous chondrocyte implantation of the knee.

Authors:  S L J James; D A Connell; A Saifuddin; J A Skinner; T W R Briggs
Journal:  Eur Radiol       Date:  2006-01-25       Impact factor: 5.315

3.  Magnetization transfer analysis of cartilage repair tissue: a preliminary study.

Authors:  F Palmieri; F De Keyzer; F Maes; I Van Breuseghem
Journal:  Skeletal Radiol       Date:  2006-12       Impact factor: 2.199

4.  Matrix-induced autologous chondrocyte implantation of the knee: mid-term and long-term follow-up by MR arthrography.

Authors:  Eugenio Genovese; Mario Ronga; Maria Gloria Angeretti; Raffaele Novario; Anna Leonardi; Mauro Albrizio; Leonardo Callegari; Carlo Fugazzola
Journal:  Skeletal Radiol       Date:  2010-05-06       Impact factor: 2.199

Review 5.  Bone marrow lesions and subchondral bone pathology of the knee.

Authors:  Elizaveta Kon; Mario Ronga; Giuseppe Filardo; Jack Farr; Henning Madry; Giuseppe Milano; Luca Andriolo; Nogah Shabshin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-13       Impact factor: 4.342

6.  Is the clinical outcome after cartilage treatment affected by subchondral bone edema?

Authors:  Giuseppe Filardo; Elizaveta Kon; Alessandro Di Martino; Francesco Perdisa; Maurizio Busacca; Francesco Tentoni; Federica Balboni; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-12-14       Impact factor: 4.342

7.  Bifunctional Labeling of Rabbit Mesenchymal Stem Cells for MR Imaging and Fluorescence Microscopy.

Authors:  Markus T Berninger; Pablo Rodriguez-Gonzalez; Franz Schilling; Bernhard Haller; Thorsten Lichtenstein; Andreas B Imhoff; Ernst J Rummeny; Martina Anton; Stephan Vogt; Tobias D Henning
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

8.  Graft hypertrophy of matrix-based autologous chondrocyte implantation: a two-year follow-up study of NOVOCART 3D implantation in the knee.

Authors:  Thomas R Niethammer; Matthias F Pietschmann; Annie Horng; Björn P Roßbach; Andreas Ficklscherer; Volkmar Jansson; Peter E Müller
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-03-01       Impact factor: 4.342

Review 9.  MR imaging of cartilage and its repair in the knee--a review.

Authors:  S Trattnig; S Domayer; G W Welsch; T Mosher; F Eckstein
Journal:  Eur Radiol       Date:  2009-03-13       Impact factor: 5.315

10.  Autologous chondrocyte implantation to repair knee cartilage injury: ultrastructural evaluation at 2 years and long-term follow-up including muscle strength measurements.

Authors:  Sverre Løken; Tom C Ludvigsen; Turid Høysveen; Inger Holm; Lars Engebretsen; Finn P Reinholt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-07-02       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.